In association with a prolific dietician, Lenskart emphasizes on eye health during COVID-19 Lenskart, the leading Omni Channel destination for eyewear in India, announced its customer-centric campaign “Eye Care Conversations with Eye Experts". In the wake of the nationwide lockdown, venturing out has reached a stage

67% of hospitalized COVID-19 patients may present with additional organ dysfunction syndromes Cytokine Storm appears to be common in severe cases of COVID-19. This is an umbrella term wherein a massive release of cytokines; i.e. immune proteins that may lead to multi-organ involvement. This uncontrolled reaction

In its efforts to help small and medium healthcare providers in the country deliver better patient care with agility, Microsoft has announced the launch of ‘Healthcare In A Box’ suite of offerings. Designed to provide secure patient experiences with improved operational efficiency while being remotely

Public healthcare, in the last decade, has been a low priority for India. Our public health expenditure was just 1.29% of the country’s GDP in 2019-20, far lower than the global average of 6%. In 2018, we were behind even our BRIC peers in the area of public

With a mission of giving second chances at life to blood cancer patients, DKMS-BMST is expanding its footprints across India in registering potential lifesavers and saving lives! This world blood cancer day, DKMS-BMST celebrates a milestone of registering over 42,000 potential life savers in a time

Messenger RNA (mRNA) based vaccine technology is emerging as one of the frontrunners among the technologies being evaluated to develop a vaccine for COVID-19, with eighteen candidates currently in development globally, according to GlobalData, a leading data and analytics company. Keshalini Sabaratnam, Pharma Analyst at

Siemens Healthineers started shipping its total antibody tests globally, including to the largest analyzer installed base in the U.S. The company has a total of 20,000 systems worldwide and will ramp up its production capacity to more than 50 million antibody tests per month as

As per the MHA & MoHFW regulations in March, the hospitals had to postpone elective surgeries to reduce the risk of patients being exposed to the novel coronavirus. This led to a huge backlog of patients awaiting treatment and surgeries. The gradual relaxation of the

COVID-19 has apparently pause the world and we are continuing the fight to prevent it , trying to develop vaccine to eradicate it but due to globalization, with increased global integration and travel, urbanization, and greater exploitation of the natural environment , it has led

CHOSOURCE platform to be combined with Rentschler Biopharma’s novel in-house cell line development process to provide speed, stability and high yield Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Horizon Discovery, a global leader in the application of gene editing